
This episode explores the potential of AI in revolutionizing drug discovery, a process that traditionally takes 12 to 15 years and is fraught with complexity and cost. AI models are being customized for drug discovery tasks, offering exciting possibilities for accelerating the process. However, limitations and challenges, including safety concerns and regulatory frameworks, need to be addressed.
Join the discussion — sign in to leave a comment.
Log in to comment